- Home
- AGNCM vs CADL Comparison
AGNCM vs CADL Comparison
Compare AGNCM & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
AGNCM
AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
Current Price
Current Price
Company Overview
Basic Information| Metric | AGNCM | CADL |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 339.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AGNCM | CADL |
|---|---|---|
| Price | $24.97 | $6.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.43 |
| AVG Volume (30 Days) | 19.1K | ★ 1.0M |
| Earning Date | 01-26-2026 | 11-13-2025 |
| Dividend Yield | ★ 8.89% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $956,000,000.00 | N/A |
| Revenue This Year | $8.02 | N/A |
| Revenue Next Year | $65.46 | N/A |
| P/E Ratio | $16.93 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $23.01 | $4.25 |
| 52 Week High | $25.60 | $13.68 |
Technical Indicators
Market Signals| Indicator | AGNCM | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 63.11 | 61.02 |
| Support Level | $24.94 | $5.45 |
| Resistance Level | $25.09 | $6.14 |
| Average True Range (ATR) | 0.14 | 0.41 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 88.73 | 45.49 |
Price Performance
Historical ComparisonAbout AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.